Protagonist Therapeutics Inc (PTGX) Stock Price, Quote, News & History

PTGXNASDAQ
$102.62
-2.93-2.78%
At close: Apr 23, 5:00 PM EST
$102.62
N/A
After Hours: 4:00 PM EST

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
57.67M
Investing Cash Flow (TTM)
-49.33M
Financing Cash Flow (TTM)
22.86M
Free Cash Flow (TTM)
56.08M
Capital Expenditure (TTM)
-1.59M
Net Change in Cash (TTM)
31.20M

Analyst Trends and Forecast

2
Dec 25
2
Jan
3
Feb
4
1
Mar
2
Apr
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$6.18B
PE Ratio (TTM)
-
PE Ratio (FWD)
25.25
PEG Ratio (TTM)
-
PS Ratio (TTM)
145.82
PB Ratio (TTM)
10.96
Earnings Yield % (TTM)
-1.94%
Earnings Yield % (FWD)
3.96%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
119.65
Book Value / Share
$9.63

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$128.39M
Debt to Equity
0.02
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$106.34
Close
$102.62
Volume / Avg.
651.59K / 761.70K
Day Range
$102.26 - $106.98
52 Wk Range
41.29 - 107.84
Market Cap
$6.55B
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
52
Short Interest
16.13%
Days to Cover
7.64

About

Sector
Health Care
Industry
Biotechnology
Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology,...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Protagonist Therapeutics (PTGX) stock?

A

You can purchase shares of Protagonist Therapeutics (NASDAQ:PTGX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Protagonist Therapeutics (PTGX) competitors?

Q

What is the forecast, or price target, for Protagonist Therapeutics (PTGX) stock?

A

Protagonist Therapeutics has a consensus price target of $93.44.

Q

What is the current price for Protagonist Therapeutics (PTGX)?

A

The stock price for Protagonist Therapeutics (NASDAQ: PTGX) is $102.62 last updated April 23, 2026 at 4:00 PM EDT.

Q

Does Protagonist Therapeutics (PTGX) pay a dividend?

A

There are no upcoming dividends for Protagonist Therapeutics.

Q

When is Protagonist Therapeutics (NASDAQ:PTGX) reporting earnings?

A

Protagonist Therapeutics does not have any upcoming earnings scheduled.

Q

Is Protagonist Therapeutics (PTGX) going to split?

A

There is no upcoming split for Protagonist Therapeutics.

Q

What sector and industry does Protagonist Therapeutics (PTGX) operate in?

A

Protagonist Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.